Skip to main content
. 2020 Sep 18;21(18):6847. doi: 10.3390/ijms21186847

Figure 4.

Figure 4

IL-17A, IFNγ and IL-4 serum levels in new-onset DMARD-naïve RA patients. Data represent the mean value serum levels of IL-17A, IFNγ and IL-4 in (Inline graphic) RA patients and (Inline graphic) as healthy controls (panels A, B and C). All values are expressed as the mean serum levels ± S.E.M. *, p < 0.05 for RA patients vs. healthy controls.